News

FDA approval of VYKAT XR for hyperphagia in Prader-Willi Syndrome marks a major milestone for Soleno Therapeutics.
The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...
With that said, here are the 11 Best Genomics Stocks to Buy According to Hedge Funds.
Many stars have joined forces with their children on the big and small screen. From Carrie Fisher and Billie Lourd to Eugene ...
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) has announced a 1-for-10 reverse stock split of its common stock, effective from 4:01 p.m. Eastern Time on June 18, 2025. This move is aimed at increasing ...